Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | June 26, 2013 |
| Target | Kiadis Pharma |
| Sector | Life Science |
| Investor(s) |
Alta Partners
EQT Life Sciences |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 58 of 59 |
| Sector: Life Science | 49 of 50 |
| Type: Venture | 47 of 48 |
| Country: Netherlands | 1 of 1 |
| Year: 2013 | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-15 |
Kite Pharma
Santa Monica, California, United States Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-08-23 |
Pathwork Diagnostics
Redwood City, California, United States Pathwork Diagnostics Inc. is a privately held company that develops and delivers innovative molecular diagnostics for oncology. Pathwork's Tissue of Origin Test identifies the source of cancers that are difficult to classify and increases oncologists’ confidence in their treatment approaches. It is the only FDA-approved molecular diagnostic test for tissue of origin. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| Deal Context for Investor | # |
|---|---|
| Overall | 4 of 47 |
| Sector: Life Science | 2 of 30 |
| Type: Venture | 4 of 39 |
| Country: Netherlands | 2 of 10 |
| Year: 2013 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-11-05 |
Lumeon
Boston, Massachusetts, United States Lumeon enables healthcare organizations to orchestrate and automate systems and processes, bringing situational awareness to care operations to deliver high-performance, team-centered healthcare. Lumeon Care Pathway Management (CPM) platform and suite of solutions empower health organizations to take control of their end-to-end care delivery model and maximize the use of resources. Lumeon was founded in 2005 and is based in Boston, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-08 |
MedEye
Den Bosch, Netherlands MedEye is developing and marketing the MedEye product, a revolutionary approach to prevent medication errors in hospitals and improve efficiency. MedEye is based in Den Bosch, Netherlands. |
Buy | - |
